Table 2

Comparison of the genotype frequencies between control subjects and HIV/AIDS patients
SNP Genotype Location/functional effect Healthy subjects HIV/AIDS patients Global p-value
n (freq) n (freq)
NR1I2 rs3732356T>G T/T Intron 3 95 (0.605) 162 (0.549) 0.031
T/G 50 (0.318) 123 (0.417)
G/G 12 (0.076) 10 (0.034)
NR1I2 rs2472677C>T C/C Intron 1, Disrupts HNF3B TFB site 57 (0.368) 97 (0.365) 0.917
C/T 75 (0.484) 133 (0.500)
T/T 23 (0.148) 36 (0.135)
NR1I2 rs6785049G>A G/G Intron 5 128 (0.853) 264 (0.950) 0.002
G/A 21 (0.140) 14 (0.050)
A/A 1 (0.007) 0 (0.000)
NR1I3 rs2307424C>T C/C Exon 5, Pro180Pro 138 (0.879) 270 (0.915) 0.216
C/T 19 (0.121) 25 (0.085)
NR1I3 rs3003596T>C T/T Intron 3 51 (0.325) 100 (0.341) 0.659
T/C 72 (0.459) 140 (0.478)
C/C 34 (0.217) 53 (0.181)
NR1I3 rs2502815C>T C/C Intron 3 88 (0.564) 180 (0.610) 0.173
C/T 53 (0.340) 100 (0.339)
T/T 15 (0.096) 15 (0.051)

Swart et al.

Swart et al. BMC Medical Genetics 2012 13:112   doi:10.1186/1471-2350-13-112

Open Data